Table 2.
Treatment Groups | Mean ∆F ± SD | % Inhibition of Fluorescence Loss Relative to Control | Mean ∆Z ± SD | % Inhibition of Mineral Loss Relative to Control |
---|---|---|---|---|
Control (untreated) | 23.33±4.59 | - | 933.2±183.6 | - |
NaF | 19.69±2.82 | 15.6% | 771.85±110.54 | 17% |
0% S-PRG filler | 23.91±3.53b | -2.5% | 968.36±142.96b | -3.8% |
1% S-PRG filler | 12.00±2.47a,b,c | 48.6% | 466.88±96.08a,b,c | 50% |
5% S-PRG filler | 9.03±1.39a,b,c | 61.3% | 360.79±55.53a,b,c | 61.3% |
20% S-PRG filler | 7.60±1.09a,b,c,d | 67.4% | 304.04±43.6a,b,c,d | 67.4% |
30% S-PRG filler | 7.05±0.37a,b,c,d | 69.8% | 274.95±14.43a,b,c,d | 70.5% |
aSignificantly different from Control; bSignificantly different from NaF; cSignificantly different from 0% S-PRG filler; dSignificantly different from 1% S-PRG filler.